Home
Live Updates
PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement : comparemela.com
PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement
/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...
Related Keywords
,
Pavmed Inc ,
Veris Health Inc ,
Nasdaq Stock Market ,
Veris Health ,
Lucid Diagnostics Inc ,
Nasdaq ,
Nasdaq Listing Rule ,
Extension Notice ,
Veris Cancer Care ,
Lucid Diagnostics ,
Esophageal Cell Collection Device ,
comparemela.com © 2020. All Rights Reserved.